These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ritonavir: expanded access begins, warning on drug interactions.
    Author: James JS.
    Journal: AIDS Treat News; 1996 Jan 19; (no 239):4. PubMed ID: 11363086.
    Abstract:
    Abbott Laboratories is providing ritonavir, a protease inhibitor, through an expanded access program. Abbott warns that the drug's use should be monitored very closely. Ritonavir blocks a liver enzyme and its use with medications that are normally metabolized by the liver may cause toxic levels to build quickly. Call Project Inform for a list of drugs which should not be taken with ritonavir.
    [Abstract] [Full Text] [Related] [New Search]